1. Biochemical and toxicity evaluation of Retama sphaerocarpa extracts and in-silico investigation of phenolic compounds as potential inhibitors against HPV16 E6 oncoprotein.
- Author
-
Moujane, Soumia, Bouadid, Ismail, Bouymajane, Aziz, Younes, Filali Zegzouti, Benlyas, Mohamed, Mohammed, Bouachrine, Cacciola, Francesco, Vinci, Roberto Laganà, Tropea, Alessia, Mondello, Luigi, Altemimi, Ammar B., Eddouks, Mohamed, and Moualij, Benaissa
- Subjects
- *
DRUG toxicity , *PAPILLOMAVIRUS diseases , *COMPUTER-assisted molecular modeling , *PHENOMENOLOGICAL biology , *BIOCHEMISTRY , *IN vivo studies , *PLANT extracts , *RATS , *PHENOLS , *ONCOGENES , *ANIMAL experimentation , *LEAVES - Abstract
Cervical cancer is a type of cancer which affects the cervix cells. The conventional treatments for cervical cancer including surgery, chemotherapy, and radiotherapy are only effective in premature stages and less effective in late stages of this tumor. Therefore, the therapeutic strategies based on biologically active substances from plants are needed to develop for the treatment of cervical cancer. The aim of the present study was to assess in vivo toxicity, hematological and biochemical blood parameters in Wistar rats fed Retama sphaerocarpa aqueous leaf extract (RS-AE), as well as to perform in silico molecular docking studies and dynamic simulation of phenolic compounds against HPV16 oncoprotein E6 in order to identify potential inhibitors. RS-AE was found not to induce acute or sub-acute oral toxicity or significant alterations in hematological and biochemical blood parameters in Wistar rats. A total of 11 phenolic compounds were identified in RS-AE, including dihydrodaidzein glucuronide, chrysoperiol pentoside, genistin and vitexin, which turned out to have the highest binding affinity to HPV16 oncoprotein E6. Based on these results, these RS-AE phenolic compounds could be used as natural drugs against the HPV16 E6 oncoprotein. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF